Zai Lab (ZLAB) News Today → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free ZLAB Stock Alerts $20.00 +1.00 (+5.26%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 4:09 AM | marketbeat.comHsbc Holdings PLC Has $1.57 Million Stake in Zai Lab Limited (NASDAQ:ZLAB)Hsbc Holdings PLC decreased its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 82.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 57,348 shares of the company's stock after selling 270,433 shares duringJune 8 at 1:59 PM | marketbeat.comBrilliance Asset Management Ltd. Grows Stake in Zai Lab Limited (NASDAQ:ZLAB)Brilliance Asset Management Ltd. boosted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 177.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 435,926 shares of the company's stock after buyingJune 7 at 3:25 PM | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading Up 4.2%Zai Lab (NASDAQ:ZLAB) Stock Price Up 4.2%June 5, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading Down 2.1%Zai Lab (NASDAQ:ZLAB) Stock Price Down 2.1%June 4, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up to $18.00Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $18.00June 2, 2024 | marketbeat.comAllianz Asset Management GmbH Purchases 140,461 Shares of Zai Lab Limited (NASDAQ:ZLAB)Allianz Asset Management GmbH lifted its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 26.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 679,524 shares of the company's stock afterJune 2, 2024 | americanbankingnews.comZai Lab Limited (NASDAQ:ZLAB) Short Interest UpdateJune 1, 2024 | americanbankingnews.comZai Lab (NASDAQ:ZLAB) Sees Large Volume IncreaseMay 31, 2024 | americanbankingnews.comZai Lab (NASDAQ:ZLAB) Shares Gap Down to $18.46May 30, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Sees Strong Trading VolumeZai Lab (NASDAQ:ZLAB) Sees Large Volume IncreaseMay 23, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.16Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.16May 22, 2024 | businesswire.comZai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque PsoriasisMay 21, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Down 4.4% Zai Lab (NASDAQ:ZLAB) Stock Price Down 4.4%May 20, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up to $19.40Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $19.40May 20, 2024 | markets.businessinsider.comZai Lab, Innoviva: China Oks XACDURO For Hospital-Acquired, Ventilator-Associated Pneumonia In 18+May 20, 2024 | businesswire.comZai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in ChinaMay 17, 2024 | insidertrades.comZai Lab Limited (NASDAQ:ZLAB) Insider Sells $213,300.00 in StockMay 17, 2024 | finance.yahoo.comInsider Sale: Chief Legal Officer of Zai Lab Ltd (ZLAB) Sells SharesMay 16, 2024 | marketbeat.comFrazor Titus Edmondson III Sells 10,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 10,000 shares of Zai Lab stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $21.33, for a total value of $213,300.00. Following the completion of the transaction, the insider now owns 16,408 shares of the company's stock, valued at $349,982.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.May 16, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.85Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.85May 16, 2024 | finance.yahoo.comZai Lab Announces Participation in May and June Investor ConferencesMay 16, 2024 | businesswire.comZai Lab Announces Participation in May and June Investor ConferencesMay 15, 2024 | markets.businessinsider.comAnalyst Upgrades Zai Lab’s Price Objective on Strong Drug Portfolio and Growth ProspectsMay 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Zai Lab (ZLAB), Alphatec Holdings (ATEC)May 14, 2024 | businesswire.comZai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in ChinaMay 13, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading Up 9.7%Zai Lab (NASDAQ:ZLAB) Shares Up 9.7%May 13, 2024 | marketwatch.comZai Lab Shares Rise 11% After Augtyro NDA Approved in ChinaMay 13, 2024 | stockhouse.comZai Lab Announces Approval of AUGTYRO(TM) (repotrectinib) for Patients with ROS1-positive NSCLC by China's NMPAMay 13, 2024 | markets.businessinsider.comChina Approves Zai Lab's AUGTYRO For ROS1-Positive NSCLC TreatmentMay 12, 2024 | businesswire.comZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China's NMPAMay 11, 2024 | finance.yahoo.comZai Lab Limited (NASDAQ:ZLAB) Just Released Its First-Quarter Results And Analysts Are Updating Their EstimatesMay 10, 2024 | finance.yahoo.comZai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketwatch.comZai Labs Shares Rise 26% After Narrower-Than-Expected 1Q LossMay 9, 2024 | marketbeat.comSegantii Capital Management Ltd Sells 101,430 Shares of Zai Lab Limited (NASDAQ:ZLAB)Segantii Capital Management Ltd trimmed its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 5.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687,569 shares of the company's stock aMay 9, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Releases Earnings Results, Beats Estimates By $0.38 EPSZai Lab (NASDAQ:ZLAB - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.93) by $0.38. The firm had revenue of $87.15 million for the quarter, compared to analyst estimates of $77.07 million. Zai Lab had a negative return on equity of 37.07% and a negative net margin of 125.46%. During the same period last year, the company earned ($0.51) EPS.May 9, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up After Earnings BeatZai Lab (NASDAQ:ZLAB) Shares Gap Up Following Earnings BeatMay 8, 2024 | investorplace.comZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | finance.yahoo.comZai Lab Announces First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 8, 2024 | markets.businessinsider.comHere's what Wall Street expects from Zai Lab's earnings reportMay 7, 2024 | markets.businessinsider.comHere's what Wall Street expects from Zai Lab's earningsMay 2, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.90Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.90April 30, 2024 | finance.yahoo.comZai Lab Limited's (NASDAQ:ZLAB) Profit OutlookApril 27, 2024 | marketbeat.comVivo Capital LLC Acquires 119,521 Shares of Zai Lab Limited (NASDAQ:ZLAB)Vivo Capital LLC lifted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 29.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 531,198 shares of the company's stocApril 25, 2024 | marketbeat.comZai Lab Limited Forecasted to Post FY2024 Earnings of ($3.50) Per Share (NASDAQ:ZLAB)Zai Lab Limited (NASDAQ:ZLAB - Free Report) - Research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for shares of Zai Lab in a report released on Tuesday, April 23rd. Cantor Fitzgerald analyst L. Chen now anticipates that the company will post earnings per share of ($3.April 24, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Up 5.3%Zai Lab (NASDAQ:ZLAB) Shares Up 5.3%April 22, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up to $14.07Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $14.07April 21, 2024 | wsj.comZai Lab Ltd. ADRApril 19, 2024 | finance.yahoo.comZai Lab Limited (ZLAB)April 17, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Down 2.4% Zai Lab (NASDAQ:ZLAB) Trading Down 2.4%April 17, 2024 | marketbeat.comGenesis Investment Management LLP Sells 339,503 Shares of Zai Lab Limited (NASDAQ:ZLAB)Genesis Investment Management LLP trimmed its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 32.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 692,663 shares of the company's stock after selling 339,503 Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution ZLAB Media Mentions By Week ZLAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼1.090.76▲Average Medical News Sentiment ZLAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼54▲ZLAB Articles Average Week Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cerevel Therapeutics News Legend Biotech News Intra-Cellular Therapies News Jazz Pharmaceuticals News Blueprint Medicines News Viking Therapeutics News Ionis Pharmaceuticals News Organon & Co. News Madrigal Pharmaceuticals News Summit Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored